Received May 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No symptoms of issues have been reported.; HCP reported administering VARIVAX to a 4 month old male patient by mistake; This spontaneous report was received from a Physician and refers to a 4-month-old male patient with no reactions or allergies reported. The patient's medical history, concurrent conditions and concomitant therapies were not reported. 19-MAY-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (expiration date: 19-MAY-2025), dose: 0.5 mL, (lot #,route of administration was reported as injectable, frequency, anatomical location, expiration date and indication were not reported) with sterile diluent (MERCK STERILE DILUENT), dose: 0.5 mL (lot #,route of administration was reported as injectable, frequency, anatomical location, expiration date and indication were not reported) by mistake for prophylaxis. No symptoms of issues had been reported